SAN

79.36

+0.43%↑

SHL.DE

42.25

+2%↑

ORNBV.FI

69.25

-0.07%↓

QDEL

23.48

-2.33%↓

ACB

3.76

+5.92%↑

SAN

79.36

+0.43%↑

SHL.DE

42.25

+2%↑

ORNBV.FI

69.25

-0.07%↓

QDEL

23.48

-2.33%↓

ACB

3.76

+5.92%↑

SAN

79.36

+0.43%↑

SHL.DE

42.25

+2%↑

ORNBV.FI

69.25

-0.07%↓

QDEL

23.48

-2.33%↓

ACB

3.76

+5.92%↑

SAN

79.36

+0.43%↑

SHL.DE

42.25

+2%↑

ORNBV.FI

69.25

-0.07%↓

QDEL

23.48

-2.33%↓

ACB

3.76

+5.92%↑

SAN

79.36

+0.43%↑

SHL.DE

42.25

+2%↑

ORNBV.FI

69.25

-0.07%↓

QDEL

23.48

-2.33%↓

ACB

3.76

+5.92%↑

Kodu・Aktsiate loetelu・Laboratorios Farmaceuticos Rovi SA

Laboratorios Farmaceuticos Rovi SA

Suletud

SektorTervishoid

78.6 -0.32

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

78.5

Max

78.75

Põhinäitajad
By Trading Economics
Sissetulek	49M 76M
Müük	51M 210M
P/E Sektori keskmine	32.405 110.024
Aktsiakasum	1.135
Dividenditootlus	1.21
Kasumimarginaal	35.965
Töötajad	2,197
EBITDA	49M 84M

Dividendid
By Dow Jones
Dividenditootlus Sektori keskmine	1.21% 2.26%
Järgmine tulemuste avaldamine	25. veebr 2026

Turustatistika
By TradingEconomics
Turukapital	693M 3.9B
Eelmine avamishind	78.92
Eelmine sulgemishind	78.6

Uudiste sentiment

By Acuity

24%

76%

45 / 351 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Weak Bullish Evidence

51.1 / N/A Toetus ja vastupanu

Laboratorios Farmaceuticos Rovi SA Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

20. veebr 2026, 17:37 UTC

Omandamised, ülevõtmised, äriostud

Paramount Regulatory Waiting Period for Warner Bid Expires -- Update

20. veebr 2026, 16:18 UTC

Suurimad hinnamuutused turgudel

Footwear Stocks Rise After Supreme Court Strikes Down Tariffs

20. veebr 2026, 23:12 UTC

Omandamised, ülevõtmised, äriostud

FERC Authorizes TXNM Energy Acquisition by Blackstone Infrastructure

20. veebr 2026, 22:12 UTC

Tulu

Equinox Gold: Announces Filing of 2025 Audited Fincl Statements

20. veebr 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

20. veebr 2026, 21:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

20. veebr 2026, 21:23 UTC

Tulu

These Stocks Are Today's Movers: Grail, Corning, Comfort Systems USA, Opendoor, Akamai, Chemours, and More -- Barrons.com

20. veebr 2026, 21:20 UTC

Market Talk

Century Aluminum Backs Trump's Tariffs After SCOTUS Ruling -- Market Talk

20. veebr 2026, 21:01 UTC

Omandamised, ülevõtmised, äriostud

Want to Win the Warner Bros. Discovery Takeover Battle? 'Walk Away Now.' -- Barrons.com

20. veebr 2026, 20:38 UTC

Market Talk

U.S. Natural Gas Gains Ahead of Chilly Weekend -- Market Talk

20. veebr 2026, 20:17 UTC

Market Talk

Oil Futures Mixed As Market Awaits U.S.-Iran Moves -- Market Talk

20. veebr 2026, 20:11 UTC

Market Talk

Traders Await Word on USMCA Exemption For Trump's Global 10% Tariff -- Market Talk

20. veebr 2026, 19:59 UTC

Market Talk

U.S. Tariff Ruling Could Make Things Worse for Mexico -- Market Talk

20. veebr 2026, 19:58 UTC

Market Talk

Omandamised, ülevõtmised, äriostud

Netflix Seen as Not Needing Warner Bros. Deal -- Market Talk

20. veebr 2026, 19:49 UTC

Market Talk

Mexico's Revised 4Q GDP Expected to Confirm Pick-Up -- Market Talk

20. veebr 2026, 19:09 UTC

Market Talk

Precious Metals Settle Higher After Tariff Ruling -- Market Talk

20. veebr 2026, 19:00 UTC

Market Talk

U.S. Oil, Gas Rig Counts Unchanged on Week -- Market Talk

20. veebr 2026, 18:28 UTC

Market Talk

Ontario Premier Warns Fight Against U.S. Tariffs Isn't Over -- Market Talk

20. veebr 2026, 18:20 UTC

Market Talk

Tariff Ruling Seen Positive for Some Retailers, Mixed for Others -- Market Talk

20. veebr 2026, 18:05 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

20. veebr 2026, 18:04 UTC

Market Talk

Trade Uncertainty in Canada to Remain Until USMCA Resolved -- Market Talk

20. veebr 2026, 17:38 UTC

Market Talk

Canada's Small Firms Look Toward Increased U.S. Tariff Opposition -- Market Talk

20. veebr 2026, 17:24 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

20. veebr 2026, 17:24 UTC

Market Talk

Correction to Treasury Yields Fall Market Talk

20. veebr 2026, 17:20 UTC

Market Talk

Financial Services Roundup: Market Talk

20. veebr 2026, 16:53 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

20. veebr 2026, 16:53 UTC

Market Talk

Canada Dollar Steady, Market Focus on USMCA Review -- Market Talk

20. veebr 2026, 16:45 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

20. veebr 2026, 16:45 UTC

Market Talk

U.K. Public Finances Supportive of Gilts in Near-Term -- Market Talk

20. veebr 2026, 16:40 UTC

Market Talk

Trade Threats Facing Canada Not Removed by Supreme Court's Ruling -- Market Talk

Võrdlus sarnastega

Hinnamuutus

Laboratorios Farmaceuticos Rovi SA Prognoos

Hinnangu Konsensus

By TipRanks

0 ratings

Osta

Hoia

Müü

Põhineb 0 analüütiku instrumendi Laboratorios Farmaceuticos Rovi SA aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

51.1 / N/AToetus ja vastupanu

Recent bullish events outweigh bearish events.

Bearish events outweigh bullish events.

Sentiment

By Acuity

45 / 351 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Laboratorios Farmaceuticos Rovi SA

Laboratorios Farmaceuticos Rovi, S.A. engages in the research, development, manufacture, and marketing of pharmaceutical products in Spain and internationally. The company provides products for cardiology, osteoarticular/women's health, anesthesia /pain, diagnostic imaging contrast agents, central nervous system, urology, endocrinology, respiratory, and primary healthcare areas. Its principal products include Ameride, Bertanel, Bluxam, Enoxaparin Rovi, Calcium Vitamine D3 Rovi, Exxiv, Prinvil, Rhodogil, Glufan, Hibor, Hirobriz Breezhaler, Neparvis, Medicebran, Medikinet, Mysimba, Orvatez, Tryptizol, Ulunar Breezhaler, and Volutsa; and hospital products, such as Iomeron and Iopamiro, Multihance and Y Prohance, Sonovue, Empowercta+, Empowermr, and CT Express, Fibrilin, and Sodium Heparin Rovi. It also provides contract-manufacturing services to other companies for a range of pharmaceutical forms, including prefilled syringes, vials, suppositories, tablets, and sachets. Laboratorios Farmaceuticos Rovi, S.A. was incorporated in 1946 and is headquartered in Madrid, Spain. Laboratorios Farmaceúticos Rovi, S.A. is a subsidiary of Norbel Inversiones, S.L.